Task: Answer the multiple-choice question.
Question: Which drug exhibits a 14.507\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
[a] CC(C(=O)N1CCc2ccccc21)N(C)CC(=O)Nc1cccc(F)c1
[b] Cc1cccc2c(N=O)c(O)n(CCc3ccccc3)c12
[c] CC(C)OCCCN1C=C2C(=O)C(C)(OC(=O)CCc3ccccc3)C(=O)C=C2C=C1c1ccc(C#N)cc1
[d] COc1ccc(/C=C/C=C2\NC(=S)NC2=O)cc1
Answer: d. COc1ccc(/C=C/C=C2\NC(=S)NC2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(/C=C/C=C2\NC(=S)NC2=O)cc1
COc1ccc(/C=C/C=C2\NC(=S)NC2=O)cc1
(5Z)-5-[(E)-3-(4-methoxyphenyl)prop-2-enylidene]-2-sulfanylideneimidazolidin-4-one